Charles A. Rowland Jr., Director at Blueprint Medicines Corp (BPMC), sold 22,036 shares at $96.08 ($2.1M) on 2019-06-20, disclosed to the SEC on 2019-06-24.
Open-market sale of $2.1M BPMC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.83 | 9,271 | $879K | 42.0% |
| 2 | $94.83 | 9,271 | $879K | 42.0% |
| 3 | $96.08 | 1,600 | $154K | 7.3% |
| 4 | $96.69 | 947 | $92K | 4.4% |
| 5 | $96.69 | 947 | $92K | 4.4% |
| Total | $95.08 avg | 22,036 |
| $2.1M |
| 100% |
| Filing → |
| VKTX | SELL | 2023-05-18 | $1.0M | — | Filing → |
| GBIO | BUY | 2022-09-20 | $83K | — | Filing → |
| GBIO | BUY | 2022-09-19 | $552K | — | Filing → |